Frances Hackman
Impact in
- Immunology and Allergy top 10%
- Allergic Rhinitis and Sensitization
-
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS drug development and treatment
- COVID-19 Clinical Research Studies
Papers in
-
- HIV/AIDS drug development and treatment 2
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 1
- SARS-CoV-2 detection and testing 1
-
- Allergic Rhinitis and Sensitization 3
- Co-authors
- Richard Allan (3 shared papers)John D. Davis (3 shared papers)Sima S. Toussi (3 shared papers)Gary Layton (2 shared papers)Haihong Shi (2 shared papers)Peter Phillips (1 shared paper)Ravi Shankar Prasad Singh (2 shared papers)Michael Binks (2 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (2 papers)British Journal of Clinical Pharmacology (1 paper)AIDS (1 paper)Journal of Allergy and Clinical Immunology (1 paper)Clinical Therapeutics (1 paper)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Frances Hackman
9 papers receiving 245 citations
Peers
Comparison fields: 5 of 56
- Immunology and Allergy 46
- Infectious Diseases 99
- Virology 20
- Pharmacology 19
- Sensory Systems 10
Countries citing papers authored by Frances Hackman
This map shows the geographic impact of Frances Hackman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances Hackman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances Hackman more than expected).
Fields of papers citing papers by Frances Hackman
This network shows the impact of papers produced by Frances Hackman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances Hackman. The network helps show where Frances Hackman may publish in the future.
Co-authors
The 25 scholars most cited alongside Frances Hackman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 95 | |
| 2 | 2011 | 46 | |
| 3 | 2009 | 34 | |
| 4 | 2008 | 23 | |
| 5 | 2014 | 18 | |
| 6 | 2022 | 16 | |
| 7 | 2022 | 9 | |
| 8 | 2010 | 7 | |
| 9 | 2014 | 3 |
About Frances Hackman
Frances Hackman is a scholar working on Infectious Diseases, Immunology and Allergy, Computational Theory and Mathematics, Molecular Biology and Pharmacology, having authored 9 papers that have together received 251 indexed citations. Recurring topics across this work include Allergic Rhinitis and Sensitization (3 papers), Computational Drug Discovery Methods (2 papers), HIV/AIDS drug development and treatment (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (1 paper), SARS-CoV-2 detection and testing (1 paper), Biochemical and Molecular Research (1 paper) and Asthma and respiratory diseases (1 paper). The work is most often cited by research in Immunology and Allergy (46 citations), Infectious Diseases (99 citations), Virology (20 citations), Pharmacology (19 citations) and Sensory Systems (10 citations). Frances Hackman has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Richard Allan, John D. Davis, Sima S. Toussi, Gary Layton, Haihong Shi, Peter Phillips, Ravi Shankar Prasad Singh, Michael Binks, Lien Van Eyck and Sylvester Pawlak. Their work appears in journals such as Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology, AIDS, Journal of Allergy and Clinical Immunology and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.